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background:  Patients with severe AS can exhibit impaired GLS despite preserved LVEF. The aim of this study was to examine the changes in global 
longitudinal strain (GLS) over time among patients with severe aortic stenosis (AS) and preserved ejection fraction (LVEF) during a period of medical 
management.
methods:  Patients with severe AS, LVEF>50% and two echocardiographic studies at least 180 days apart without intervening aortic valve 
replacement were identified from our clinical database. Changes in GLS between baseline and the second echocardiogram were assessed and 
related to long term clinical outcomes.
results:  A total of 130 patients with 260 echocardiograms were included. During the period between the baseline and second echocardiogram 
(median 351 days,IQR: 263-496) GLS worsened significantly (-17.2%±3.6 to -15.3%±3.6, p<0.001). During long term clinical follow-up after the 
second echocardiogram (median 725 days, IQR: 302-1364) a total of 36 patients died (27.7%). A GLS worse than -16% was significantly associated 
with increased mortality (HR: 3.0; CI: 1.40-6.30, p=0.005). From baseline to the second echocardiogram a total of 34 patients out of 86 with a 
baseline GLS better than -16% developed a GLS worse than -16%.
conclusions:  In patients with severe AS and preserved LVEF observed during an asymptomatic phase, GLS deteriorates progressively in a 
substantial proportion of patients and has a significant impact on long term adverse clinical outcome.
 
